Subscribe to MDT Magazine News

Wyss Institute’s technology translation engine launches ‘Organs-on-Chips’ company

July 28, 2014 9:46 am | Comments

The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that its human 'Organs-on-Chips' technology will be commercialized by a newly formed private company to accelerate development of pharmaceutical, chemical, cosmetic, and personalized medicine products. The announcement follows a worldwide license agreement between Harvard's Office of Technology Development (OTD) and the start-up Emulate Inc.

New York Tech Startup Leading Fight Against Obesity and Chronic Disease

July 28, 2014 9:26 am | Comments

3Pound Health announced the full commercial release of Euco, a patient-engagement platform designed to expand the reach and impact of clinician-managed health and wellness programs. Euco is a disruptive innovation that recognizes the reality of today's behavior-driven healthcare challenges manifested most recognizably in obesity and chronic disease. 3Pound Health also ...


New Chlamydia and Gonorrhea Assays on the BD Viper LT System Receive FDA 510k Clearance

July 28, 2014 9:17 am | Comments

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the BD Viper LT System.


ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe

July 28, 2014 8:29 am | by PR Newswire | Comments

MUNICH, July 28, 2014 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and other chronic respiratory conditions, has won a permanent injunction in Germany against Taiwanese medical device...

Astute Medical And Ortho-Clinical Diagnostics Enter Strategic Collaboration To Advance Innovative Acute Kidney Injury Test

July 28, 2014 8:29 am | by The Associated Press | Comments

 Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition. A study recently published in the...

CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol in China

July 28, 2014 8:28 am | by The Associated Press | Comments

BEIJING--(BUSINESS WIRE)--Jul 28, 2014--CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive partnership with EUSA Pharma, a Jazz Pharmaceuticals company (Nasdaq:JAZZ), to commercialize Caphosol®...

Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago

July 28, 2014 7:32 am | by PR Newswire | Comments

MURRAY HILL and NEW PROVIDENCE, N.J., July 28, 2014 /PRNewswire/ -- Healthcare facility management and engineering professionals are invited to meet with Linde's Healthcare division experts at the ASHE Annual Conference and Technical Exhibition to be held at McCormick Place in...

Teleflex Announces European Launch of LMA SureSeal PreCurved

July 28, 2014 7:31 am | by The Associated Press | Comments

WAYNE, Pa.--(BUSINESS WIRE)--Jul 28, 2014--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced the European launch of the CE marked LMA SureSeal™ PreCurved. The LMA SureSeal PreCurved was developed from the assets acquired...


Amsel Medical Corporation and the Mayo Clinic Announce Signing of a Patent License Agreement

July 28, 2014 6:25 am | by The Associated Press | Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 28, 2014--Amsel Medical Corporation and Mayo Clinic today announced the signing of a Patent License Agreement for certain intellectual property developed by Mayo Clinic inventors (Henna Kalsi, M.D., a Mayo Clinic cardiologist, Thom W. Rooke, M.D., a Mayo...

QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients

July 28, 2014 2:30 am | by PR Newswire | Comments

HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA  for non-small cell lung cancer patients  New blood test will build on QIAGEN's...

Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020

July 25, 2014 5:33 pm | by PR Newswire | Comments

DALLAS, July 25, 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides key market data on the Australia Capsule Endoscopy Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US...

Novel Technologies Advance Brain Surgery to Benefit Patients

July 25, 2014 4:40 pm | by UC San Diego Health Sciences | Comments

Neurosurgeons at UC San Diego Health System have integrated advanced 3D imaging, computer simulation and next-generation surgical tools to perform a highly complex brain surgery through a small incision to remove deep-seated tumors. This is the first time this complex choreography of technologies has been brought together in an operating room in California.


Chemist develops x-ray vision for quality assurance

July 25, 2014 4:28 pm | by Iben Julie Schmidt, Technical Univ. of Denmark | Comments

A Technical Univ. of Denmark researcher has developed a method that uses x-rays for the rapid identification of substances present in an indeterminate powder. The new technique has the capacity to recognize advanced biological molecules such as proteins. The method therefore has enormous potential in both food production and the pharmaceutical industry, where it ...


Reading the Signals

July 25, 2014 4:04 pm | by Georgia Institue of Technology | Comments

Patients suffering from chronic liver disease often develop liver fibrosis (the accumulation of scar tissue), which frequently results in cirrhosis, which means a loss of liver function, which often comes with a choice between a liver transplant and certain death.

NIH programs to focus on emerging areas of science

July 25, 2014 3:47 pm | by National Institutes of Health | Comments

Scientific areas ripe for targeted investments in technology development and research to improve health are the focus of new programs of the National Institutes of Health's Common Fund. The programs include work to facilitate the study of how sugar modifications affect proteins, to understand the arrangement of DNA within cells in four dimensions, and to enable the development of new therapies that allow control of organ function through...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.